However, in contrast to simple obesity, where GH is low and IGF-I within normal range (89), subjects with MASLD demonstrate variable changes in the GH/IGF-I axis depending on disease severity (121123) ( Table 1 )
Injections bypass this entire issue
Specifically, glycogen phosphorylase, the enzyme mediating glycogenolysis, was significantly decreased in GDI1 deficient astrocytes Glycogen is in the brain predominantly, if not exclusively, expressed in astrocytes
Key physiological effects include: Elevated basal metabolic rate (BMR) Enhanced mitochondrial efficiency and endurance Fat loss while preserving lean muscle mass For a full breakdown of NNMT inhibition, NAD preservation, and the role of SIRT1, see 5-Amino-1MQ for Beginners: Dosage, Benefits, and Peptide Stacks Explained
, , , , .